Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

This study has been completed.
Information provided by (Responsible Party):
ViiV Healthcare Identifier:
First received: January 24, 2013
Last updated: September 8, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)